- Title
- Orally Administered Factor Xa Inhibitor, Rivaroxaban: A Novel Thromboembolic Prophylaxis Agent
- Creators
- RICARDO J KOMOTAR - 1 TECHNICAL & CLINICAL RESEARCHROBERT M STARKE - 1 TECHNICAL & CLINICAL RESEARCHE. SANDER CONNOLLY - 1 TECHNICAL & CLINICAL RESEARCH
- Publication Details
- Neurosurgery, Vol.63(4), pp.N10-N11
- Publisher
- Oxford University Press
- Academic Unit
- Miller School of Medicine; UMMG Dept of Neurological Surgery
- Language
- English
- Resource Type
- Journal article
- PMID
- 18981864
- Record Identifier
- 991031560861902976
Journal article
Orally Administered Factor Xa Inhibitor, Rivaroxaban: A Novel Thromboembolic Prophylaxis Agent
Neurosurgery, Vol.63(4), pp.N10-N11
2008-10-01
PMID: 18981864
Metrics
44 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.75 Blood Clotting
- 1.75.271 Pulmonary Embolism
- Web Of Science research areas
- Clinical Neurology
- Surgery
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites